1
|
Brycht M, Poltorak L, Baluchová S, Sipa K, Borgul P, Rudnicki K, Skrzypek S. Electrochemistry as a Powerful Tool for Investigations of Antineoplastic Agents: A Comprehensive Review. Crit Rev Anal Chem 2024; 54:1017-1108. [PMID: 35968923 DOI: 10.1080/10408347.2022.2106117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
Abstract
Cancer is most frequently treated with antineoplastic agents (ANAs) that are hazardous to patients undergoing chemotherapy and the healthcare workers who handle ANAs in the course of their duties. All aspects related to hazardous oncological drugs illustrate that the monitoring of ANAs is essential to minimize the risks associated with these drugs. Among all analytical techniques used to test ANAs, electrochemistry holds an important position. This review, for the first time, comprehensively describes the progress done in electrochemistry of ANAs by means of a variety of bare or modified (bio)sensors over the last four decades (in the period of 1982-2021). Attention is paid not only to the development of electrochemical sensing protocols of ANAs in various biological, environmental, and pharmaceutical matrices but also to achievements of electrochemical techniques in the examination of the interactions of ANAs with deoxyribonucleic acid (DNA), carcinogenic cells, biomimetic membranes, peptides, and enzymes. Other aspects, including the enantiopurity studies, differentiation between single-stranded and double-stranded DNA without using any label or tag, studies on ANAs degradation, and their pharmacokinetics, by means of electrochemical techniques are also commented. Finally, concluding remarks that underline the existence of a significant niche for the basic electrochemical research that should be filled in the future are presented.
Collapse
Affiliation(s)
- Mariola Brycht
- Faculty of Chemistry, Department of Inorganic and Analytical Chemistry, University of Lodz, Lodz, Poland
| | - Lukasz Poltorak
- Faculty of Chemistry, Department of Inorganic and Analytical Chemistry, University of Lodz, Lodz, Poland
| | - Simona Baluchová
- Faculty of Science, Department of Analytical Chemistry, UNESCO Laboratory of Environmental Electrochemistry, Charles University, Prague 2, Czechia
- Department of Precision and Microsystems Engineering, Delft University of Technology, Delft, The Netherlands
| | - Karolina Sipa
- Faculty of Chemistry, Department of Inorganic and Analytical Chemistry, University of Lodz, Lodz, Poland
| | - Paulina Borgul
- Faculty of Chemistry, Department of Inorganic and Analytical Chemistry, University of Lodz, Lodz, Poland
| | - Konrad Rudnicki
- Faculty of Chemistry, Department of Inorganic and Analytical Chemistry, University of Lodz, Lodz, Poland
| | - Sławomira Skrzypek
- Faculty of Chemistry, Department of Inorganic and Analytical Chemistry, University of Lodz, Lodz, Poland
| |
Collapse
|
2
|
Chiorcea-Paquim AM, Oliveira-Brett AM. Electrochemistry of chemotherapeutic alkylating agents and their interaction with DNA. J Pharm Biomed Anal 2022; 222:115036. [DOI: 10.1016/j.jpba.2022.115036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2022] [Revised: 09/06/2022] [Accepted: 09/07/2022] [Indexed: 10/14/2022]
|
3
|
Rodrigues ESB, de Macêdo IYL, Silva GNDME, de Carvalho e Silva A, Gil HPV, Neves BJ, Gil EDS. DNA-Based Electrodes and Computational Approaches on the Intercalation Study of Antitumoral Drugs. Molecules 2021; 26:molecules26247623. [PMID: 34946705 PMCID: PMC8709249 DOI: 10.3390/molecules26247623] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2021] [Revised: 11/25/2021] [Accepted: 11/26/2021] [Indexed: 11/28/2022] Open
Abstract
The binding between anticancer drugs and double-stranded DNA (dsDNA) is a key issue to understand their mechanism of action, and many chemical methods have been explored on this task. Molecular docking techniques successfully predict the affinity of small molecules into the DNA binding sites. In turn, various DNA-targeted drugs are electroactive; in this regard, their electrochemical behavior may change according to the nature and strength of interaction with DNA. A carbon paste electrode (CPE) modified with calf thymus ds-DNA (CPDE) and computational methods were used to evaluate the drug–DNA intercalation of doxorubicin (DOX), daunorubicin (DAU), idarubicin (IDA), dacarbazine (DAR), mitoxantrone (MIT), and methotrexate (MTX), aiming to evaluate eventual correlations. CPE and CPDE were immersed in pH 7 0.1 mM solutions of each drug with different incubation times. As expected, the CPDE response for all DNA-targeted drugs was higher than that of CPE, evidencing the drug–DNA interaction. A peak current increase of up to 10-fold was observed; the lowest increase was seen for MTX, and the highest increase for MIT. Although this increase in the sensitivity is certainly tied to preconcentration effects of DNA, the data did not agree entirely with docking studies, evidencing the participation of other factors, such as viscosity, interfacial electrostatic interactions, and coefficient of diffusion.
Collapse
Affiliation(s)
- Edson Silvio Batista Rodrigues
- Lafam—Laboratory for Pharmaceutical and Environmental Analysis, Faculdade de Farmácia, Universidade Federal de Goiás, Goiânia 74605-170, Brazil; (E.S.B.R.); (I.Y.L.d.M.); (G.N.d.M.e.S.)
| | - Isaac Yves Lopes de Macêdo
- Lafam—Laboratory for Pharmaceutical and Environmental Analysis, Faculdade de Farmácia, Universidade Federal de Goiás, Goiânia 74605-170, Brazil; (E.S.B.R.); (I.Y.L.d.M.); (G.N.d.M.e.S.)
| | - Giovanna Nascimento de Mello e Silva
- Lafam—Laboratory for Pharmaceutical and Environmental Analysis, Faculdade de Farmácia, Universidade Federal de Goiás, Goiânia 74605-170, Brazil; (E.S.B.R.); (I.Y.L.d.M.); (G.N.d.M.e.S.)
| | - Arthur de Carvalho e Silva
- LabMol—Laboratory for Molecular Modeling and Drug Design, Faculdade de Farmácia, Universidade Federal de Goiás, Goiânia 74605-170, Brazil; (A.d.C.e.S.); (H.P.V.G.); (B.J.N.)
| | - Henric Pietro Vicente Gil
- LabMol—Laboratory for Molecular Modeling and Drug Design, Faculdade de Farmácia, Universidade Federal de Goiás, Goiânia 74605-170, Brazil; (A.d.C.e.S.); (H.P.V.G.); (B.J.N.)
| | - Bruno Junior Neves
- LabMol—Laboratory for Molecular Modeling and Drug Design, Faculdade de Farmácia, Universidade Federal de Goiás, Goiânia 74605-170, Brazil; (A.d.C.e.S.); (H.P.V.G.); (B.J.N.)
| | - Eric de Souza Gil
- Lafam—Laboratory for Pharmaceutical and Environmental Analysis, Faculdade de Farmácia, Universidade Federal de Goiás, Goiânia 74605-170, Brazil; (E.S.B.R.); (I.Y.L.d.M.); (G.N.d.M.e.S.)
- Correspondence:
| |
Collapse
|
4
|
Campos-Sandoval JA, Gómez-García MC, Santos-Jiménez JDL, Matés JM, Alonso FJ, Márquez J. Antioxidant responses related to temozolomide resistance in glioblastoma. Neurochem Int 2021; 149:105136. [PMID: 34274381 DOI: 10.1016/j.neuint.2021.105136] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2021] [Revised: 06/20/2021] [Accepted: 07/08/2021] [Indexed: 10/20/2022]
Abstract
Glioblastoma remains one of the most challenging and devastating cancers, with only a very small proportion of patients achieving 5-year survival. The current standard of care consists of surgery, followed by radiation therapy with concurrent and maintenance chemotherapy with the alkylating agent temozolomide. To date, this drug is the only one that provides a significant survival benefit, albeit modest, as patients end up acquiring resistance to this drug. As a result, tumor progression and recurrence inevitably occur, leading to death. Several factors have been proposed to explain this resistance, including an upregulated antioxidant system to keep the elevated intracellular ROS levels, a hallmark of cancer cells, under control. In this review, we discuss the mechanisms of chemoresistance -including the important role of glioblastoma stem cells-with emphasis on antioxidant defenses and how agents that impair redox balance (i.e.: sulfasalazine, erastin, CB-839, withaferin, resveratrol, curcumin, chloroquine, and hydroxychloroquine) might be advantageous in combined therapies against this type of cancer.
Collapse
Affiliation(s)
- José A Campos-Sandoval
- Departamento de Biología Molecular y Bioquímica, Canceromics Lab. Facultad de Ciencias, Universidad de Málaga, 29071 Málaga, Spain, and Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain.
| | - María C Gómez-García
- Departamento de Biología Molecular y Bioquímica, Canceromics Lab. Facultad de Ciencias, Universidad de Málaga, 29071 Málaga, Spain, and Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain
| | - Juan de Los Santos-Jiménez
- Departamento de Biología Molecular y Bioquímica, Canceromics Lab. Facultad de Ciencias, Universidad de Málaga, 29071 Málaga, Spain, and Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain
| | - José M Matés
- Departamento de Biología Molecular y Bioquímica, Canceromics Lab. Facultad de Ciencias, Universidad de Málaga, 29071 Málaga, Spain, and Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain
| | - Francisco J Alonso
- Departamento de Biología Molecular y Bioquímica, Canceromics Lab. Facultad de Ciencias, Universidad de Málaga, 29071 Málaga, Spain, and Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain
| | - Javier Márquez
- Departamento de Biología Molecular y Bioquímica, Canceromics Lab. Facultad de Ciencias, Universidad de Málaga, 29071 Málaga, Spain, and Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain
| |
Collapse
|
5
|
Foroughi MM, Jahani S, Aramesh-Broujeni Z, Rostaminasab Dolatabad M. A label-free electrochemical biosensor based on 3D cubic Eu 3+/Cu 2O nanostructures with clover-like faces for the determination of anticancer drug cytarabine. RSC Adv 2021; 11:17514-17525. [PMID: 35479699 PMCID: PMC9033006 DOI: 10.1039/d1ra01372f] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2021] [Accepted: 04/26/2021] [Indexed: 12/20/2022] Open
Abstract
The present research utilized a simplified procedure for developing a novel electro-chemical DNA biosensor based on a carbon paste electrode (CPE) modified with three-dimensional (3D) cubic Eu3+/Cu2O nanostructures with clover-like faces (Eu3+/Cu2O CLFNs). The modified electrode was applied to monitor electro-chemical interactions between dsDNA and cytarabine for the first time. Then, the decreased oxidation signal of guanine following the interactions between cytarabine and dsDNA was utilized as an indicator for selectively determining cytarabine using differential pulse voltammetry (DPV). According to the findings, the oxidation peak current of guanine was linearly proportionate with the cytarabine concentration in the range between 0.01 and 90 μM. Additionally, the limit of quantification (LOQ) and the limit of detection (LOD) respectively equaled 9.4 nM and 2.8 nM. In addition, the repeatability, applicability and reproducibility of this analysis to drug dosage forms and human serum samples were investigated. Furthermore, UV-vis spectroscopy, DPV, docking and viscosity measurements were applied to elucidate the interaction mechanism of dsDNA with cytarabine. It was found that this DNA biosensor may be utilized to sensitively, accurately and rapidly determine cytarabine.
Collapse
Affiliation(s)
| | - Shohreh Jahani
- Noncommunicable Diseases Research Center, Bam University of Medical Sciences Bam Iran
| | - Zahra Aramesh-Broujeni
- Department of Clinical Laboratory, AlZahra Hospital, Isfahan University of Medical Sciences Isfahan Iran
| | | |
Collapse
|
6
|
Peerzada MN, Hamel E, Bai R, Supuran CT, Azam A. Deciphering the key heterocyclic scaffolds in targeting microtubules, kinases and carbonic anhydrases for cancer drug development. Pharmacol Ther 2021; 225:107860. [PMID: 33895188 DOI: 10.1016/j.pharmthera.2021.107860] [Citation(s) in RCA: 25] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2021] [Revised: 03/31/2021] [Accepted: 04/06/2021] [Indexed: 12/17/2022]
Abstract
Heterocyclic scaffolds are widely utilized for drug design by taking into account the molecular structure of therapeutic targets that are related to a broad spectrum of ailments, including tumors. Such compounds display various covalent and non-covalent interactions with the specific residues of the target proteins while causing their inhibition. There is a substantial number of heterocyclic compounds approved for cancer treatment, and these compounds function by interacting with different therapeutic targets involved in tumorogenesis. In this review, we trace and emphasize the privileged heterocyclic pharmacophores that have immense potency against several essential chemotherapeutic tumor targets: microtubules, kinases and carbonic anhydrases. Potent compounds currently undergoing pre-clinical and clinical studies have also been assessed for ascertaining the effective class of chemical scaffolds that have significant therapeutic potential against multiple malignancies. In addition, we also describe briefly the role of heterocyclic compounds in various chemotherapy regimens. The optimized molecular hybridization of delineated motifs may result in the discovery of more active anticancer therapeutics and circumvent the development of resistance by specific targets in the future.
Collapse
Affiliation(s)
- Mudasir Nabi Peerzada
- Medicinal Chemistry Research Laboratory, Department of Chemistry, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India
| | - Ernest Hamel
- Molecular Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA
| | - Ruoli Bai
- Molecular Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA
| | - Claudiu T Supuran
- Department of NEUROFARBA, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Polo Scientifico, Via U. Schiff 6, 50019 Sesto Fiorentino, Florence, Italy.
| | - Amir Azam
- Medicinal Chemistry Research Laboratory, Department of Chemistry, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India.
| |
Collapse
|
7
|
DNA Electrochemical Biosensors for In Situ Probing of Pharmaceutical Drug Oxidative DNA Damage. SENSORS 2021; 21:s21041125. [PMID: 33562790 PMCID: PMC7915242 DOI: 10.3390/s21041125] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/22/2021] [Revised: 02/01/2021] [Accepted: 02/01/2021] [Indexed: 12/20/2022]
Abstract
Deoxyribonucleic acid (DNA) electrochemical biosensors are devices that incorporate immobilized DNA as a molecular recognition element on the electrode surface, and enable probing in situ the oxidative DNA damage. A wide range of DNA electrochemical biosensor analytical and biotechnological applications in pharmacology are foreseen, due to their ability to determine in situ and in real-time the DNA interaction mechanisms with pharmaceutical drugs, as well as with their degradation products, redox reaction products, and metabolites, and due to their capacity to achieve quantitative electroanalytical evaluation of the drugs, with high sensitivity, short time of analysis, and low cost. This review presents the design and applications of label-free DNA electrochemical biosensors that use DNA direct electrochemical oxidation to detect oxidative DNA damage. The DNA electrochemical biosensor development, from the viewpoint of electrochemical and atomic force microscopy (AFM) characterization, and the bottom-up immobilization of DNA nanostructures at the electrode surface, are described. Applications of DNA electrochemical biosensors that enable the label-free detection of DNA interactions with pharmaceutical compounds, such as acridine derivatives, alkaloids, alkylating agents, alkylphosphocholines, antibiotics, antimetabolites, kinase inhibitors, immunomodulatory agents, metal complexes, nucleoside analogs, and phenolic compounds, which can be used in drug analysis and drug discovery, and may lead to future screening systems, are reviewed.
Collapse
|
8
|
Bolat G. Investigation of poly(CTAB-MWCNTs) composite based electrochemical DNA biosensor and interaction study with anticancer drug Irinotecan. Microchem J 2020. [DOI: 10.1016/j.microc.2020.105426] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
|
9
|
Rupar J, Aleksić MM, Dobričić V, Brborić J, Čudina O. An electrochemical study of 9-chloroacridine redox behavior and its interaction with double-stranded DNA. Bioelectrochemistry 2020; 135:107579. [DOI: 10.1016/j.bioelechem.2020.107579] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2019] [Revised: 05/25/2020] [Accepted: 05/31/2020] [Indexed: 10/24/2022]
|
10
|
Shoja Y, Kermanpur A, Karimzadeh F, Ghodsi J, Rafati AA, Adhami S. Electrochemical molecularly bioimprinted siloxane biosensor on the basis of core/shell silver nanoparticles/EGFR exon 21 L858R point mutant gene/siloxane film for ultra-sensing of Gemcitabine as a lung cancer chemotherapy medication. Biosens Bioelectron 2019; 145:111611. [PMID: 31550632 DOI: 10.1016/j.bios.2019.111611] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2019] [Revised: 08/14/2019] [Accepted: 08/17/2019] [Indexed: 11/16/2022]
Abstract
In search for improvements in bioanalysis electrochemical sensors, for better assessment of anti-cancer drugs, it is necessary for their detection limits to be minimized and the sensitivity and selectivity to be surpassed simultaneously; whereas, resolving any probable interfering with other medical treatments are considered. In this work, a novel approach was adopted for detection and assessment of Gemcitabine (GEM) as an anti-cancer drug based on evaluating its interaction with EGFR exon 21-point mutant gene. An electrochemical nanobiosensor was invented based on a new molecularly bioimprinted siloxane polymer (MBIS) strategy; in which the EGFR exon 21 acts as an identification probe. The roles of multi-walled carbon nanotubes and Ag nanoparticles (NPs) are to perform as a signal amplifier. The MBIS film was prepared by acid-catalysed hydrolysis/condensation of the sample solution, containing Ag NPs, ds-DNA of EGFR exon 21 point mutant gene, GEM as a template molecule, 3-(aminopropyl) trimethoxysilane (APTMS) and tetraethoxysilane. The interaction between the dsDNA and GEM was investigated by employing the modified biosensor and monitoring oxidation signal of guanine and adenine. The produced biosensor was characterized by XRD, FE-SEM, EDS, FT-IR and differential pulse voltammetry. The oxidation signals of adenine and guanine were in linear range when the device was subjected to various concentrations of GEM, from 1.5 to -93 μM, where a low detection limit 12.5 nmol L-1, and 48.8 nmol L-1 were recorded by guanine and adenine respectively. The developed biosensor did perform very well when employed for the actual samples; the stability was also approved which was acceptable for a reasonable time.
Collapse
Affiliation(s)
- Yalda Shoja
- Department of Materials Engineering, Isfahan University of Technology, Isfahan, 84156-83111, Iran.
| | - Ahmad Kermanpur
- Department of Materials Engineering, Isfahan University of Technology, Isfahan, 84156-83111, Iran
| | - Fathallah Karimzadeh
- Department of Materials Engineering, Isfahan University of Technology, Isfahan, 84156-83111, Iran
| | - Javad Ghodsi
- Department of Physical Chemistry, Faculty of Chemistry, Bu-Ali Sina University, P.O.Box 65174, Hamedan, Iran.
| | - Amir Abbas Rafati
- Department of Physical Chemistry, Faculty of Chemistry, Bu-Ali Sina University, P.O.Box 65174, Hamedan, Iran
| | - Siavash Adhami
- Department of Materials Engineering, Isfahan University of Technology, Isfahan, 84156-83111, Iran
| |
Collapse
|
11
|
Nemčeková K, Labuda J, Milata V, Blaškovičová J, Sochr J. Interaction of DNA and mononucleotides with theophylline investigated using electrochemical biosensors and biosensing. Bioelectrochemistry 2018; 123:182-189. [DOI: 10.1016/j.bioelechem.2018.05.004] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2018] [Revised: 05/02/2018] [Accepted: 05/02/2018] [Indexed: 11/26/2022]
|
12
|
Pathak PK, Kumar A, Prasad BB. A novel electrocatalytic nanocomposite of reduced graphene oxide/silver nanocube hybrid decorated imprinted polymer for ultra-trace sensing of temozolomide. NEW J CHEM 2018. [DOI: 10.1039/c8nj01824c] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A new nanocomposite of reduced graphene oxide/silver nanocube hybrid decorated molecularly imprinted polymer at the surface of a screen-printed carbon electrode was developed for the electroanalysis of an anticancerous drug, temozolomide, at the ultra-trace level.
Collapse
Affiliation(s)
- Purnendu Kumar Pathak
- Analytical Division
- Department of Chemistry
- Institute of Science
- Banaras Hindu University
- Varanasi 221005
| | - Anil Kumar
- Analytical Division
- Department of Chemistry
- Institute of Science
- Banaras Hindu University
- Varanasi 221005
| | - Bhim Bali Prasad
- Analytical Division
- Department of Chemistry
- Institute of Science
- Banaras Hindu University
- Varanasi 221005
| |
Collapse
|
13
|
Bruzaca EES, Lopes IC, Silva EHC, Carvalho PAV, Tanaka AA. Electrochemical oxidation of the antitumor antibiotic mitomycin C and in situ evaluation of its interaction with DNA using a DNA-electrochemical biosensor. Microchem J 2017. [DOI: 10.1016/j.microc.2017.03.030] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
14
|
Lopes IC, Oliveira-Brett AM. Human Cytochrome P450 (CYP1A2)-dsDNA Interactionin situEvaluation Using a dsDNA-electrochemical Biosensor. ELECTROANAL 2017. [DOI: 10.1002/elan.201600713] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Ilanna Campelo Lopes
- Chemistry Department; Faculty of Sciences and Technology; University of Coimbra; 3004-535 Coimbra Portugal
| | - Ana Maria Oliveira-Brett
- Chemistry Department; Faculty of Sciences and Technology; University of Coimbra; 3004-535 Coimbra Portugal
| |
Collapse
|
15
|
Pinheiro R, Braga C, Santos G, Bronze MR, Perry MJ, Moreira R, Brites D, Falcão AS. Targeting Gliomas: Can a New Alkylating Hybrid Compound Make a Difference? ACS Chem Neurosci 2017; 8:50-59. [PMID: 27665765 DOI: 10.1021/acschemneuro.6b00169] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
Glioblastoma (GBM) is the most common and aggressive type of brain tumor in adults. The triazene Temozolomide (TMZ), an alkylating drug, is the classical chemotherapeutic agent for gliomas, but has been disappointing against the highly invasive and resistant nature of GBM. Hybrid compounds may open new horizons within this challenge. The multicomponent therapeutic strategy here used resides on a combination of two repurposing drugs acting by different but potentially synergistic mechanisms, improved efficacy, and lower resistance effects. We synthesized a new hybrid compound (HYBCOM) by covalently binding a TMZ analogue to valproic acid, a histone deacetylase inhibitor drug that was shown to sensitize TMZ-resistant glioma cells. Advantages of this new molecule as compared to TMZ, in terms of chemotherapeutic efficacy, were investigated. Our results evidenced that HYBCOM more efficiently decreased the viability and proliferation of the GL261 glioma cells, while showing to better target the tumor cells than the functionally normal astrocytes. Increased cytotoxicity by HYBCOM may be a consequence of the improved autophagic process observed. Additionally, HYBCOM changed the morphology of GL261 cells into a nonpolar, more rounded shape, impairing cell migration ability. Most interesting, and in opposite to TMZ, cells exposed to HYBCOM did not enhance the expression of drug resistance proteins, a major issue in the treatment of GBM. Overall, our studies indicate that HYBCOM has promising chemotherapeutic benefits over the classical TMZ, and future studies should assess if the treatment translates into efficacy in glioblastoma experimental models and reveal clinical benefits in GBM patients.
Collapse
Affiliation(s)
- Rui Pinheiro
- Research Institute for
Medicines (iMed.ULisboa), ‡Department of Biochemistry and Human
Biology, §Department
of Pharmaceutical Chemistry and Therapeutics, and ∥Department of Toxicological and Bromatological
Sciences, Faculty of Pharmacy, Universidade de Lisboa, Avenida Professor
Gama Pinto, 1649-003 Lisbon, Portugal
| | - Cláudia Braga
- Research Institute for
Medicines (iMed.ULisboa), ‡Department of Biochemistry and Human
Biology, §Department
of Pharmaceutical Chemistry and Therapeutics, and ∥Department of Toxicological and Bromatological
Sciences, Faculty of Pharmacy, Universidade de Lisboa, Avenida Professor
Gama Pinto, 1649-003 Lisbon, Portugal
| | - Gisela Santos
- Research Institute for
Medicines (iMed.ULisboa), ‡Department of Biochemistry and Human
Biology, §Department
of Pharmaceutical Chemistry and Therapeutics, and ∥Department of Toxicological and Bromatological
Sciences, Faculty of Pharmacy, Universidade de Lisboa, Avenida Professor
Gama Pinto, 1649-003 Lisbon, Portugal
| | - Maria R. Bronze
- Research Institute for
Medicines (iMed.ULisboa), ‡Department of Biochemistry and Human
Biology, §Department
of Pharmaceutical Chemistry and Therapeutics, and ∥Department of Toxicological and Bromatological
Sciences, Faculty of Pharmacy, Universidade de Lisboa, Avenida Professor
Gama Pinto, 1649-003 Lisbon, Portugal
| | - Maria J. Perry
- Research Institute for
Medicines (iMed.ULisboa), ‡Department of Biochemistry and Human
Biology, §Department
of Pharmaceutical Chemistry and Therapeutics, and ∥Department of Toxicological and Bromatological
Sciences, Faculty of Pharmacy, Universidade de Lisboa, Avenida Professor
Gama Pinto, 1649-003 Lisbon, Portugal
| | - Rui Moreira
- Research Institute for
Medicines (iMed.ULisboa), ‡Department of Biochemistry and Human
Biology, §Department
of Pharmaceutical Chemistry and Therapeutics, and ∥Department of Toxicological and Bromatological
Sciences, Faculty of Pharmacy, Universidade de Lisboa, Avenida Professor
Gama Pinto, 1649-003 Lisbon, Portugal
| | - Dora Brites
- Research Institute for
Medicines (iMed.ULisboa), ‡Department of Biochemistry and Human
Biology, §Department
of Pharmaceutical Chemistry and Therapeutics, and ∥Department of Toxicological and Bromatological
Sciences, Faculty of Pharmacy, Universidade de Lisboa, Avenida Professor
Gama Pinto, 1649-003 Lisbon, Portugal
| | - Ana S. Falcão
- Research Institute for
Medicines (iMed.ULisboa), ‡Department of Biochemistry and Human
Biology, §Department
of Pharmaceutical Chemistry and Therapeutics, and ∥Department of Toxicological and Bromatological
Sciences, Faculty of Pharmacy, Universidade de Lisboa, Avenida Professor
Gama Pinto, 1649-003 Lisbon, Portugal
| |
Collapse
|
16
|
Ivić MLA, Petrović SD, Mijin DŽ. Contribution to the Recent Advances in Electrochemical Analysis of Pharmaceuticals. ACTA ACUST UNITED AC 2016. [DOI: 10.1007/978-3-319-31849-3_2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/10/2023]
|
17
|
Phase Transition Detection in Accumulation of a Potential Anticancer Drug Cl-IPBD with DNA: Supercoiled and Linear pUC19 Plasmids. Electrochim Acta 2016. [DOI: 10.1016/j.electacta.2016.05.159] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
|
18
|
|
19
|
Tığ GA, Zeybek B, Pekyardımcı Ş. Electrochemical DNA biosensor based on poly(2,6-pyridinedicarboxylic acid) modified glassy carbon electrode for the determination of anticancer drug gemcitabine. Talanta 2016; 154:312-21. [DOI: 10.1016/j.talanta.2016.03.049] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2015] [Revised: 03/11/2016] [Accepted: 03/15/2016] [Indexed: 10/22/2022]
|
20
|
Erasimus H, Gobin M, Niclou S, Van Dyck E. DNA repair mechanisms and their clinical impact in glioblastoma. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH 2016; 769:19-35. [PMID: 27543314 DOI: 10.1016/j.mrrev.2016.05.005] [Citation(s) in RCA: 116] [Impact Index Per Article: 14.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/25/2016] [Accepted: 05/04/2016] [Indexed: 12/18/2022]
Abstract
Despite surgical resection and genotoxic treatment with ionizing radiation and the DNA alkylating agent temozolomide, glioblastoma remains one of the most lethal cancers, due in great part to the action of DNA repair mechanisms that drive resistance and tumor relapse. Understanding the molecular details of these mechanisms and identifying potential pharmacological targets have emerged as vital tasks to improve treatment. In this review, we introduce the various cellular systems and animal models that are used in studies of DNA repair in glioblastoma. We summarize recent progress in our knowledge of the pathways and factors involved in the removal of DNA lesions induced by ionizing radiation and temozolomide. We introduce the therapeutic strategies relying on DNA repair inhibitors that are currently being tested in vitro or in clinical trials, and present the challenges raised by drug delivery across the blood brain barrier as well as new opportunities in this field. Finally, we review the genetic and epigenetic alterations that help shape the DNA repair makeup of glioblastoma cells, and discuss their potential therapeutic impact and implications for personalized therapy.
Collapse
Affiliation(s)
- Hélène Erasimus
- NORLUX Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health (LIH), 84 Val Fleuri, L-1526 Luxembourg, Luxembourg
| | - Matthieu Gobin
- NORLUX Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health (LIH), 84 Val Fleuri, L-1526 Luxembourg, Luxembourg
| | - Simone Niclou
- NORLUX Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health (LIH), 84 Val Fleuri, L-1526 Luxembourg, Luxembourg
| | - Eric Van Dyck
- NORLUX Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health (LIH), 84 Val Fleuri, L-1526 Luxembourg, Luxembourg.
| |
Collapse
|
21
|
DNA-modified boron-doped diamond electrode as a simple electrochemical platform for detection of damage to DNA by antihypertensive amlodipine. MONATSHEFTE FUR CHEMIE 2016. [DOI: 10.1007/s00706-016-1729-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
|
22
|
Topkaya SN, Serindere G, Ozder M. Determination of DNA Hypermethylation Using Anti-cancer Drug-Temozolomide. ELECTROANAL 2015. [DOI: 10.1002/elan.201501027] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
23
|
A sensitive electrochemical DNA biosensor for antineoplastic drug 5-fluorouracil based on glassy carbon electrode modified with poly(bromocresol purple). Talanta 2015; 144:793-800. [DOI: 10.1016/j.talanta.2015.06.077] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2015] [Revised: 06/22/2015] [Accepted: 06/26/2015] [Indexed: 01/26/2023]
|
24
|
Diculescu VC, Oliveira-Brett AM. In situ electrochemical evaluation of dsDNA interaction with the anticancer drug danusertib nitrenium radical product using the DNA-electrochemical biosensor. Bioelectrochemistry 2015; 107:50-7. [PMID: 26523506 DOI: 10.1016/j.bioelechem.2015.10.004] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2015] [Revised: 09/22/2015] [Accepted: 10/23/2015] [Indexed: 10/22/2022]
Abstract
Danusertib is a kinase inhibitor and anti-cancer drug. The evaluation of the interaction between danusertib and dsDNA was investigated in bulk solution and using the dsDNA-electrochemical biosensor. The dsDNA-danusertib interaction occurs in two sequential steps. First, danusertib binds electrostatically todsDNA phosphate backbone through the positively charged piperazine moiety. The second step involved the pyrrolo-pyrazolemoiety and led to small morphological modifications in the dsDNA double helix which were electrochemically characterised through the changes of guanine and adenine residue oxidation peaks and confirmed by electrophoretic and spectrophotometric measurements. The nitrenium cation radical product of danusertib amino group oxidation was electrochemically generated in situ on the dsDNA-electrochemical biosensor surface. The danusertib nitrenium cation radical redox metabolite was covalently attached to the C8 of guanine residues preventing their oxidation. An interaction mechanism of dsDNA-danusertib is proposed and the formation of the danusertib redox nitrenium radical metabolite-guanine adduct explained.
Collapse
Affiliation(s)
- Victor Constantin Diculescu
- Chemistry Department, Faculty of Sciences and Technology, University of Coimbra, 3004-535, Coimbra, Portugal
| | - Ana Maria Oliveira-Brett
- Chemistry Department, Faculty of Sciences and Technology, University of Coimbra, 3004-535, Coimbra, Portugal.
| |
Collapse
|
25
|
Tomé LI, Marques NV, Diculescu VC, Oliveira-Brett AM. In situ dsDNA-bevacizumab anticancer monoclonal antibody interaction electrochemical evaluation. Anal Chim Acta 2015; 898:28-33. [DOI: 10.1016/j.aca.2015.09.049] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2015] [Revised: 09/28/2015] [Accepted: 09/29/2015] [Indexed: 11/26/2022]
|
26
|
Altay C, Eksin E, Congur G, Erdem A. Electrochemical monitoring of the interaction between Temozolamide and nucleic acids by using disposable pencil graphite electrodes. Talanta 2015; 144:809-15. [PMID: 26452894 DOI: 10.1016/j.talanta.2015.07.017] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2015] [Revised: 07/03/2015] [Accepted: 07/04/2015] [Indexed: 11/16/2022]
Abstract
Temozolomide (TMZ) is an anticancer drug used for the treatment of adult brain tumour and skin cancer. The biomolecular interaction between TMZ and DNA was investigated for the first time in this study using disposable pencil graphite electrodes (PGEs) in combination with electrochemical techniques. The surface confined interactions between TMZ and different type of nucleic acids were performed. Before/after surface confined interaction process, the oxidation signals of TMZ, guanine and adenine were measured using differential pulse voltammetry (DPV) and PGE and accordingly, the changes at the oxidation signals were evaluated. The detection limit (DL) was also estimated based on the oxidation signal of TMZ. The interaction of TMZ with single stranded poly [A], poly [G], or double stranded poly [A]-poly[T] and poly [G]-poly[C] was also explored. Moreover, cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS) techniques were utilized for detection the interaction between TMZ and DNA. The features of this single-use electrochemical sensor was discussed in comparison to other reports that were developed for TMZ detection.
Collapse
Affiliation(s)
- Cansu Altay
- Faculty Of Pharmacy, Analytical Chemistry Department, Ege University, 35100 Bornova, Izmir, Turkey; The Institute Of Natural And Applied Sciences, Biomedical Technologies Department, Ege University, 35100 Bornova, Izmir, Turkey
| | - Ece Eksin
- Faculty Of Pharmacy, Analytical Chemistry Department, Ege University, 35100 Bornova, Izmir, Turkey; The Institute Of Natural And Applied Sciences, Biotechnology Department, Ege University, 35100 Bornova, Izmir, Turkey
| | - Gulsah Congur
- Faculty Of Pharmacy, Analytical Chemistry Department, Ege University, 35100 Bornova, Izmir, Turkey; The Institute Of Natural And Applied Sciences, Biotechnology Department, Ege University, 35100 Bornova, Izmir, Turkey
| | - Arzum Erdem
- Faculty Of Pharmacy, Analytical Chemistry Department, Ege University, 35100 Bornova, Izmir, Turkey; The Institute Of Natural And Applied Sciences, Biomedical Technologies Department, Ege University, 35100 Bornova, Izmir, Turkey; The Institute Of Natural And Applied Sciences, Biotechnology Department, Ege University, 35100 Bornova, Izmir, Turkey.
| |
Collapse
|
27
|
Kurbanoglu S, Dogan-Topal B, Hlavata L, Labuda J, Ozkan SA, Uslu B. Electrochemical investigation of an interaction of the antidepressant drug aripiprazole with original and damaged calf thymus dsDNA. Electrochim Acta 2015. [DOI: 10.1016/j.electacta.2015.04.087] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
28
|
Santarino IB, Oliveira SCB, Oliveira-Brett AM. In Situ Evaluation of the Anticancer Antibody Rituximab-dsDNA Interaction Using a DNA-Electrochemical Biosensor. ELECTROANAL 2014. [DOI: 10.1002/elan.201300488] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
29
|
Lopes IC, de Oliveira SCB, Oliveira-Brett AM. Temozolomide chemical degradation to 5-aminoimidazole-4-carboxamide – Electrochemical study. J Electroanal Chem (Lausanne) 2013. [DOI: 10.1016/j.jelechem.2013.07.011] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|